The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
DUBAI / GULF TIME
CellSave Arabia, the UAE’s only licensed private stem cell biobank, is proud to be at the forefront of the regenerative medicine revolution. In 2022, the company successfully released over 100 stem cell units from its state-of-the-art laboratories for transplant to treat over 12 diseases in the UAE. These achievements are a testament to CellSave Arabia’s commitment to advancing medical science and improving the lives of patients.
For over 15 years, CellSave Arabia has been offering stem cell banking services from a variety of sources including umbilical cord blood, cord tissue, cord vessel, amnion placental tissue, placental tissue, adipose tissue, bone marrow, and peripheral blood. The release of more than 100 stem cell units for successful transplants marks a significant milestone in the company’s journey to provide reliable and secure services to help safeguard the future health of hundreds of thousands of families in the region.
“At CellSave Arabia, we are proud to be providing a reliable and secure service to help safeguard the future health of families in the region†said the company’s CEO, Sarah Al-Hajali. “Our innovating and advanced laboratory facilities and experienced team of professionals have played a crucial role in the successful release of 100 stem cell units for transplants, which have helped treat over 12 diseases in the UAE, including Thalassemia, multiple myeloma, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, sarcoma, sickle cell anemia, acute myeloid leukemia, mantle cell lymphoma, multi blood disorders, and diffuse large B-cell lymphoma. We are committed to continue delivering the highest standards of service to our customers, and we look forward to helping even more families in the years to come.”